Indefinite Delivery Contract 36C26225D0004
Award Date
10/1/24
Last Date to Order
9/30/29
Federal Agency
Veterans Integrated Service Network 22
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a small disadvantaged business. The $576,677.75 single-award IDC, with a performance period through September 2029, will provide the VA with a range of radiopharmaceutical products and services to support nuclear medicine operations at the VA Greater Los Angeles Healthcare...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The contract has a ceiling value of $220,000.00 and a period of performance through March 31, 2030.
Under this IDC, Jubilant Radiopharma will provide radiopharmaceuticals and nuclear medicine products to support diagnostic and treatment capabilities for veterans at VA...
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The $2.29 million single-award IDC, with a period of performance through January 2030, is for the supply of radiopharmaceuticals, including specialized medical isotopes, diagnostic imaging agents, and therapeutic radioisotopes, to support nuclear medicine procedures, PET scans,...
This federal Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a small disadvantaged business, to provide radiopharmaceuticals and related services to the Lebanon VA Medical Center. The contract has a ceiling value of $3,059,720.83 and a period of performance through July 2025, with the possibility of four one-year option periods.
Jubilant Radiopharma, a subsidiary of...
The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, for the provision of radiopharmaceuticals. The IDC, valued at up to $2.6 million, has an ultimate completion date of March 4, 2029 and is not set-aside. As a subsidiary of Jubilant Life Sciences Limited, Jubilant Radiopharma specializes in manufacturing,...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a single-award Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a for-profit small disadvantaged business, for the supply of nuclear medicine radiopharmaceuticals. The $1.5 million IDC, which has a period of performance through April 2025, enables the VA to efficiently procure a range of specialized radioactive isotopes, imaging agents, and...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a for-profit organization, to provide radiopharmaceuticals and related products and services to support diagnostic imaging and treatment procedures at VA medical facilities. The IDC has a potential value of $3,000,000 and runs through September 30, 2028. Jubilant Radiopharma, which is...
The U.S. Department of Veterans Affairs (VA) awarded Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, an Indefinite Delivery Contract (IDC) valued at up to $39.8 million to provide radiopharmaceuticals to VA medical facilities. Jubilant Radiopharma, a for-profit organization and self-certified small disadvantaged business, will supply diagnostic imaging agents, therapeutic radiopharmaceuticals, and nuclear medicine supplies, including products such as Ga-68...
The federal contract IDV awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, is for the supply of radiopharmaceuticals. The $740,177.94 firm-fixed-price delivery order contract is part of a larger $39.8 million multiple-award Indefinite Delivery Contract (IDC) with the VA's Network Contracting Office 8, as well as additional IDVs with the VA and Defense Health...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded Jubilant Draximage Inc., doing business as Jubilant Radiopharma, Division Radiopharmaceutique, an Indefinite Delivery Contract (IDC) valued up to $3.5 million for the provision of radioactive isotopes and related radiopharmaceutical products and services. This single-award IDC with the VA VISN 10 network has a period of performance through September 30, 2026.
Under this IDC, Jubilant Radiopharma, a...